Field | Row 1 |
---|---|
adsh | 0000915389-25-000105 |
cik | 915389 |
name | EASTMAN CHEMICAL CO |
sic | 2821 |
countryba | US |
stprba | TN |
cityba | KINGSPORT |
zipba | 37660 |
bas1 | PO BOX 511 |
bas2 | 200 SOUTH WILCOX DRIVE |
baph | 4232292000 |
countryma | US |
stprma | TN |
cityma | KINGSPORT |
zipma | 37662 |
mas1 | P O BOX 511 B-54D |
mas2 | |
countryinc | US |
stprinc | DE |
ein | 621539359 |
former | |
changed | |
afs | 1-LAF |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250425 |
accepted | 2025-04-25 12:26:00.0 |
prevrpt | 0 |
detail | 1 |
instance | emn-20250331_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0000915389-25-000105 | 20250331 | Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 8491000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Additional Paid In Capital | 2476000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Assets | 14971000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 837000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Common Stock Shares Issued | 223588347.0000 | shares | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Cost Of Goods And Services Sold | 1733000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Cost Of Goods And Services Sold | 526000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Cost Of Goods And Services Sold | 511000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 96000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20250331 | Earnings Per Share Diluted | 1.5700 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Goodwill | 3632000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net | 302000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Increase Decrease In Accounts Payable Trade | 49000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Long Term Debt Noncurrent | 4736000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Net Cash Provided By Used In Operating Activities | -167000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20240331 | Net Income Loss Attributable To Noncontrolling Interest | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20241231 | Other Receivables | 381000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Payments To Acquire Property Plant And Equipment | 147000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Pension And Other Postretirement Benefits Contributions In Excess Of Less Than Expenses | 19000000.0000 | USD | 1 | 0000915389-25-000105 | |||
0000915389-25-000105 | 20240331 | Proceeds From Repayments Of Short Term Debt | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Profit Loss | 183000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Property Plant And Equipment Gross | 14130000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Revenues | 331000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Selling General And Administrative Expense | 69000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Selling General And Administrative Expense | 28000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Selling General And Administrative Expense | 167000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Short Term Borrowings | 0.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Revolving Credit Facility; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity | 5458000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity | 2000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20241231 | Treasury Stock Value | 6385000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Variable Cash Compensation In Excess Of Less Than Expenses | 78000000.0000 | USD | 1 | 0000915389-25-000105 | |||
0000915389-25-000105 | 20241231 | Assets | 2209000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Corporate Assets; | ||
0000915389-25-000105 | 20231231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -319000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -314000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Assets Current | 3901000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -419000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Common Stock Shares Issued | 223880113.0000 | shares | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Common Stock Value | 2000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Comprehensive Income Net Of Tax | 156000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Comprehensive Income Net Of Tax | 175000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Deferred Income Tax Liabilities Net | 512000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Earnings Per Share Diluted | 1.3900 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Intangible Assets Net Excluding Goodwill | 1021000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Interest Income Expense Net | -49000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Interest Income Expense Net | -49000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate Non Segment; | ||
0000915389-25-000105 | 20250331 | Interest Income Expense Net | -49000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Minority Interest | 70000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20250331 | Minority Interest | 73000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Net Income Loss Attributable To Noncontrolling Interest | 1000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Other Assets Current | 104000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Assets Current | 108000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Other Assets Noncurrent | 833000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Amortization Adjustment From A O C I Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax | -2000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -9000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -7000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Payments Of Dividends | 95000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Pension And Other Postretirement Benefit Expense | -5000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Pension And Other Postretirement Benefit Expense | -1000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Revenues | 2306000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Cost Of Goods And Services Sold | 1723000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Additional Paid In Capital | 2463000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Assets | 5735000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20241231 | Assets | 1586000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20241231 | Assets Current | 4101000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 96000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 96000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -2000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Government Incentives Cash Received | 0.0000 | USD | 1 | 0000915389-25-000105 | |||
0000915389-25-000105 | 20250331 | Gross Profit | 567000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 253000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net | 263000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Income Tax Expense Benefit | 70000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Inventory Net | 1988000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Liabilities And Stockholders Equity | 14971000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Net Cash Provided By Used In Financing Activities | -124000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20240331 | Net Income Loss | 165000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -20000000.0000 | USD | 4 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -9000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -7000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20250331 | Pension And Other Postretirement Benefits Contributions In Excess Of Less Than Expenses | 14000000.0000 | USD | 1 | 0000915389-25-000105 | |||
0000915389-25-000105 | 20250331 | Proceeds From Payments For Other Financing Activities | -9000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Proceeds From Repayments Of Short Term Debt | 285000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Property Plant And Equipment Net | 5639000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Revenues | 2310000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Selling General And Administrative Expense | 191000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Short Term Borrowings | 0.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Revolving Credit Facility; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity | 2000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity | 9490000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20240331 | Stockholders Equity | 2388000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20240331 | Stockholders Equity | 5538000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity | 2000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity | -6385000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5530000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5608000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Treasury Stock Value | 6385000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Accounts Payable And Accrued Liabilities Current | 2258000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -321000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Assets | 4608000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Assets | 1625000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Cost Of Goods And Services Sold | 492000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Deferred Income Tax Expense Benefit | -3000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Deferred Income Tax Liabilities Net | 533000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Gross Profit | 532000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Income Tax Expense Benefit | 49000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Increase Decrease In Inventories | 120000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Liabilities | 9361000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Liabilities Current | 2708000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Minority Interest | 73000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20240331 | Net Cash Provided By Used In Investing Activities | -179000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20240331 | Net Income Loss Attributable To Noncontrolling Interest | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Nonoperating Income Expense | -13000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Assets Noncurrent | 768000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Amortization Adjustment From A O C I Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax | 2000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20241231 | Other Comprehensive Income Loss Net Of Tax | 5000000.0000 | USD | 4 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20250331 | Other Liabilities Noncurrent | 886000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Restructuring Settlement And Impairment Provisions | -11000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate Non Segment; | ||
0000915389-25-000105 | 20250331 | Restructuring Settlement And Impairment Provisions | 9000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Retained Earnings Accumulated Deficit | 10099000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Selling General And Administrative Expense | 53000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Selling General And Administrative Expense | 77000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Selling General And Administrative Expense | 19000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity | -321000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity | 5871000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity Before Treasury Stock | 12256000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Accounts Receivable Net Current | 894000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Assets | 15213000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Assets | 1075000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Assets | 5875000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Common Stock Value | 2000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Cost Of Goods And Services Sold | 470000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Depreciation And Amortization | 127000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Depreciation And Amortization | 126000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20240331 | Earnings Per Share Basic | 1.4000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Government Incentives Cash Received | 11000000.0000 | USD | 1 | 0000915389-25-000105 | |||
0000915389-25-000105 | 20240331 | Increase Decrease In Inventories | 100000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Liabilities | 9027000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Minority Interest | 73000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Net Cash Provided By Used In Investing Activities | -131000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Income Loss | 165000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20250331 | Net Income Loss | 182000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | -13000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20241231 | Other Liabilities Noncurrent | 923000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Postemployment Benefits Liability Noncurrent | 624000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Profit Loss | 165000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Repayments Of Long Term Debt | 550000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Restructuring Settlement And Impairment Provisions | 11000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Restructuring Settlement And Impairment Provisions | -9000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate Non Segment; | ||
0000915389-25-000105 | 20240331 | Revenues | 523000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Selling General And Administrative Expense | 20000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20241231 | Short Term Borrowings | 0.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Commercialpaperandshorttermborrowings; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity | 2368000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity | 2463000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity | 10099000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20241231 | Treasury Stock Common Shares | 108470763.0000 | shares | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Accounts Payable And Accrued Liabilities Current | 1984000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Accounts Receivable Net Current | 791000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Assets | 1076000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Assets | 13236000000.0000 | USD | 0 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 499000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | 156000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | 176000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Cost Of Goods And Services Sold | 1778000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Cost Of Goods And Services Sold | 546000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20250331 | Increase Decrease In Accounts Payable Trade | -72000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Intangible Assets Net Excluding Goodwill | 1032000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Liabilities Current | 2269000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20231231 | Minority Interest | 72000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20241231 | Minority Interest | 73000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20240331 | Net Cash Provided By Used In Financing Activities | 148000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20250331 | Net Income Loss | 182000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Nonoperating Income Expense | -8000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | 4000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax | 1000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -7000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20240331 | Payments For Proceeds From Other Investing Activities | -6000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Payments Of Dividends | 96000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Proceeds From Issuance Of Long Term Debt | 246000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Proceeds From Payments For Other Financing Activities | -1000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Property Plant And Equipment Gross | 13985000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Repayments Of Long Term Debt | 498000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Retained Earnings Accumulated Deficit | 9559000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Revenues | 704000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Revenues | 748000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Revenues | 733000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Revenues | 719000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Advanced Materials; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Revenues | 5000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate Non Segment; | ||
0000915389-25-000105 | 20240331 | Selling General And Administrative Expense | 31000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Selling General And Administrative Expense | 181000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Stockholders Equity | 2000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity | -314000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity Before Treasury Stock | 12164000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5852000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5944000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Variable Cash Compensation In Excess Of Less Than Expenses | 109000000.0000 | USD | 1 | 0000915389-25-000105 | |||
0000915389-25-000105 | 20250331 | Assets | 4660000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Assets | 1735000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Corporate Assets; | ||
0000915389-25-000105 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 548000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 418000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Common Stock Shares Authorized | 350000000.0000 | shares | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Cost Of Goods And Services Sold | 527000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Cost Of Goods And Services Sold | 190000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Cost Of Goods And Services Sold | 176000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Deferred Income Tax Expense Benefit | -17000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 96000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 96000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Earnings Per Share Basic | 1.5800 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Interest Income Expense Net | -49000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate Non Segment; | ||
0000915389-25-000105 | 20250331 | Inventory Net | 2116000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Long Term Debt Noncurrent | 4567000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -10000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -9000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Other Operating Activities Cash Flow Statement | -66000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Other Receivables | 365000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Retained Earnings Accumulated Deficit | 10013000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Revenues | 4000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate Non Segment; | ||
0000915389-25-000105 | 20250331 | Revenues | 2290000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Revenues | 545000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Chemical Intermediates; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Revenues | 2285000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20250331 | Selling General And Administrative Expense | 182000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Selling General And Administrative Expense | 51000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Additives And Functional Products; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Stockholders Equity | -328000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20240331 | Stockholders Equity | -6083000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity | 5779000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Stockholders Equity | 10013000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity | 2476000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000915389-25-000105 | 20250331 | Treasury Stock Common Shares | 108470763.0000 | shares | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 8370000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Assets | 13004000000.0000 | USD | 0 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -49000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Cost Of Goods And Services Sold | 1705000000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 96000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20250331 | Dividends Common Stock Cash | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20250331 | Goodwill | 3642000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 214000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Increase Decrease In Accounts Receivable | 105000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Increase Decrease In Accounts Receivable | 92000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Liabilities And Stockholders Equity | 15213000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Cash Provided By Used In Operating Activities | -16000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Net Income Loss | 165000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20250331 | Net Income Loss | 182000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20250331 | Net Income Loss Attributable To Noncontrolling Interest | 1000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 8000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000915389-25-000105 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0000915389-25-000105 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20240331 | Other Operating Activities Cash Flow Statement | -38000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Payments For Proceeds From Other Investing Activities | -5000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Payments To Acquire Property Plant And Equipment | 185000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Postemployment Benefits Liability Noncurrent | 630000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Proceeds From Issuance Of Long Term Debt | 742000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20241231 | Property Plant And Equipment Net | 5615000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20240331 | Research And Development Expense | 59000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Research And Development Expense | 67000000.0000 | USD | 1 | us-gaap/2024 | |||
0000915389-25-000105 | 20231231 | Retained Earnings Accumulated Deficit | 9490000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Revenues | 288000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Fibers; Consolidation Items= Operating Segments; | ||
0000915389-25-000105 | 20241231 | Short Term Borrowings | 450000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Short Term Borrowings | 285000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Short Term Borrowings | 285000000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Commercialpaperandshorttermborrowings; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity | -319000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000915389-25-000105 | 20231231 | Stockholders Equity | -6083000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000915389-25-000105 | 20240331 | Stockholders Equity | 9559000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000915389-25-000105 | 20241231 | Stockholders Equity | 5779000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
0000915389-25-000105 | 20250331 | Stockholders Equity | 5871000000.0000 | USD | 0 | us-gaap/2024 | |||
0000915389-25-000105 | 20250331 | Stockholders Equity | -6385000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Proceeds From Issuance Of Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Long-Term Debt | The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Increase Decrease In Accounts Payable Trade | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. |
Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Postemployment Benefits Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Postemployment Benefits Liability, Noncurrent | For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer). |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
Payments Of Dividends | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Dividends | Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Variable Cash Compensation In Excess Of Less Than Expenses | 0000915389-25-000105 | 1 | 0 | monetary | D | C | Variable Cash Compensation (In Excess Of) Less Than Expenses | Variable compensation (in excess of) less than expenses. The difference between the amount of variable cash or cash equivalents compensation and the amount recorded as an expense during the period. |
Pension And Other Postretirement Benefits Contributions In Excess Of Less Than Expenses | 0000915389-25-000105 | 1 | 0 | monetary | D | C | Pension And Other Postretirement Benefits Contributions In Excess Of Less Than Expenses | The difference between the amount of cash or cash equivalents contributed during the reporting period by the entity to fund its pension plans and its non-pension postretirement benefit plans and the amount recorded as an expense during the period. |
Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Other Operating Activities Cash Flow Statement | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Operating Activities, Cash Flow Statement | Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities). |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
Dividends Common Stock Cash | us-gaap/2024 | 0 | 0 | monetary | D | D | Dividends, Common Stock, Cash | Amount of paid and unpaid common stock dividends declared with the form of settlement in cash. |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net | Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense). |
Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
Other Receivables | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Receivables | Amount due from parties in nontrade transactions, classified as other. |
Payments For Proceeds From Other Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for (Proceeds from) Other Investing Activities | Amount of cash (inflow) outflow from investing activities classified as other. |
Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
Government Incentives Cash Received | 0000915389-25-000105 | 1 | 0 | monetary | D | D | Government incentives, cash received | Government incentives, cash received |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Pension And Other Postretirement Benefit Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Pension and Other Postretirement Benefits Cost (Reversal of Cost) | Amount of cost (reversal of cost) for pension and other postretirement benefits. |
Repayments Of Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Long-Term Debt | The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. |
Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Deferred Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
Interest Income Expense Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Operating | Amount of interest income (expense) classified as operating. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
Proceeds From Payments For Other Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Short Term Borrowings | us-gaap/2024 | 0 | 0 | monetary | I | C | Short-Term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. |
Stockholders Equity Before Treasury Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Stockholders' Equity before Treasury Stock | Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings and including equity attributable to noncontrolling interests and before deducting the carrying value of treasury stock. |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
Other Comprehensive Income Loss Amortization Adjustment From A O C I Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax | Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan. |
Proceeds From Repayments Of Short Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Repayments of) Short-Term Debt | The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer. |
Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Deferred Income Tax Liabilities Net | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income Tax Liabilities, Net | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax | Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness. |
Property Plant And Equipment Gross | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Gross | Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Restructuring Settlement And Impairment Provisions | us-gaap/2024 | 0 | 0 | monetary | D | D | Restructuring, Settlement and Impairment Provisions | Amount of restructuring charges, remediation cost, and asset impairment loss. |
Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
Minority Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax | Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0000915389-25-000105 | 2 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Sales | 0 |
0000915389-25-000105 | 2 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of sales | 0 |
0000915389-25-000105 | 2 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
0000915389-25-000105 | 2 | 4 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative expenses | 0 |
0000915389-25-000105 | 2 | 5 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development expenses | 0 |
0000915389-25-000105 | 2 | 6 | IS | 0 | H | Restructuring Settlement And Impairment Provisions | us-gaap/2024 | Asset impairments, restructuring, and other charges, net | 0 |
0000915389-25-000105 | 2 | 7 | IS | 0 | H | Pension And Other Postretirement Benefit Expense | us-gaap/2024 | Other components of post-employment (benefit) cost, net | 0 |
0000915389-25-000105 | 2 | 8 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Other (income) charges, net | 1 |
0000915389-25-000105 | 2 | 9 | IS | 0 | H | Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net | us-gaap/2024 | Earnings before interest and taxes | 0 |
0000915389-25-000105 | 2 | 10 | IS | 0 | H | Interest Income Expense Net | us-gaap/2024 | Net interest expense | 1 |
0000915389-25-000105 | 2 | 11 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Earnings before income taxes | 0 |
0000915389-25-000105 | 2 | 12 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 0 |
0000915389-25-000105 | 2 | 13 | IS | 0 | H | Profit Loss | us-gaap/2024 | Net earnings | 0 |
0000915389-25-000105 | 2 | 14 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | Less: Net earnings attributable to noncontrolling interest | 0 |
0000915389-25-000105 | 2 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net earnings attributable to Eastman | 0 |
0000915389-25-000105 | 2 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic earnings per share attributable to Eastman | 0 |
0000915389-25-000105 | 2 | 19 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted earnings per share attributable to Eastman | 0 |
0000915389-25-000105 | 2 | 21 | IS | 0 | H | Profit Loss | us-gaap/2024 | Net earnings including noncontrolling interest | 0 |
0000915389-25-000105 | 2 | 23 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Change in cumulative translation adjustment | 0 |
0000915389-25-000105 | 2 | 25 | IS | 0 | H | Other Comprehensive Income Loss Amortization Adjustment From A O C I Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax | us-gaap/2024 | Amortization of unrecognized prior service credits | 0 |
0000915389-25-000105 | 2 | 27 | IS | 0 | H | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | us-gaap/2024 | Unrealized gain (loss) during period | 0 |
0000915389-25-000105 | 2 | 28 | IS | 0 | H | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax | us-gaap/2024 | Reclassification adjustment for (gains) losses included in net income, net | 1 |
0000915389-25-000105 | 2 | 29 | IS | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Total other comprehensive income (loss), net of tax | 0 |
0000915389-25-000105 | 2 | 30 | IS | 0 | H | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Comprehensive income including noncontrolling interest | 0 |
0000915389-25-000105 | 2 | 31 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | Less: Net earnings attributable to noncontrolling interest | 0 |
0000915389-25-000105 | 2 | 32 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive income attributable to Eastman | 0 |
0000915389-25-000105 | 2 | 34 | IS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings at beginning of period | 0 |
0000915389-25-000105 | 2 | 35 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net earnings attributable to Eastman | 0 |
0000915389-25-000105 | 2 | 36 | IS | 0 | H | Dividends Common Stock Cash | us-gaap/2024 | Cash dividends declared | 1 |
0000915389-25-000105 | 2 | 37 | IS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings at end of period | 0 |
0000915389-25-000105 | 3 | 3 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents | 0 |
0000915389-25-000105 | 3 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Trade receivables, net of allowance for credit losses | 0 |
0000915389-25-000105 | 3 | 5 | BS | 0 | H | Other Receivables | us-gaap/2024 | Miscellaneous receivables | 0 |
0000915389-25-000105 | 3 | 6 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories | 0 |
0000915389-25-000105 | 3 | 7 | BS | 0 | H | Other Assets Current | us-gaap/2024 | Other current assets | 0 |
0000915389-25-000105 | 3 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0000915389-25-000105 | 3 | 10 | BS | 0 | H | Property Plant And Equipment Gross | us-gaap/2024 | Properties and equipment at cost | 0 |
0000915389-25-000105 | 3 | 11 | BS | 0 | H | Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | us-gaap/2024 | Less: Accumulated depreciation | 0 |
0000915389-25-000105 | 3 | 12 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Net properties | 0 |
0000915389-25-000105 | 3 | 13 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
0000915389-25-000105 | 3 | 14 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net of accumulated amortization | 0 |
0000915389-25-000105 | 3 | 15 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other noncurrent assets | 0 |
0000915389-25-000105 | 3 | 16 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0000915389-25-000105 | 3 | 19 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Payables and other current liabilities | 0 |
0000915389-25-000105 | 3 | 20 | BS | 0 | H | Short Term Borrowings | us-gaap/2024 | Borrowings due within one year | 0 |
0000915389-25-000105 | 3 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0000915389-25-000105 | 3 | 22 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Long-term borrowings | 0 |
0000915389-25-000105 | 3 | 23 | BS | 0 | H | Deferred Income Tax Liabilities Net | us-gaap/2024 | Deferred income tax liabilities | 0 |
0000915389-25-000105 | 3 | 24 | BS | 0 | H | Postemployment Benefits Liability Noncurrent | us-gaap/2024 | Post-employment obligations | 0 |
0000915389-25-000105 | 3 | 25 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
0000915389-25-000105 | 3 | 26 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0000915389-25-000105 | 3 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock ($0.01 par value 350,000,000 shares authorized; shares issued 223,880,113 and 223,588,347 as of March 31, 2025 and December 31, 2024, respectively) | 0 |
0000915389-25-000105 | 3 | 29 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
0000915389-25-000105 | 3 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings | 0 |
0000915389-25-000105 | 3 | 31 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income (loss) | 0 |
0000915389-25-000105 | 3 | 32 | BS | 0 | H | Stockholders Equity Before Treasury Stock | us-gaap/2024 | Stockholder's Equity before Treasury Stock | 0 |
0000915389-25-000105 | 3 | 33 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Less: Treasury stock at cost (108,470,763 shares as of both March 31, 2025 and December 31, 2024) | 0 |
0000915389-25-000105 | 3 | 34 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Eastman stockholders' equity | 0 |
0000915389-25-000105 | 3 | 35 | BS | 0 | H | Minority Interest | us-gaap/2024 | Noncontrolling interest | 0 |
0000915389-25-000105 | 3 | 36 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Total equity | 0 |
0000915389-25-000105 | 3 | 37 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
0000915389-25-000105 | 3 | 38 | BS | 0 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
0000915389-25-000105 | 3 | 39 | BS | 0 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
0000915389-25-000105 | 3 | 40 | BS | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
0000915389-25-000105 | 3 | 41 | BS | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury stock at cost (in shares) | 0 |
0000915389-25-000105 | 4 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net earnings | 0 |
0000915389-25-000105 | 4 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
0000915389-25-000105 | 4 | 5 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2024 | Benefit from deferred income taxes | 0 |
0000915389-25-000105 | 4 | 7 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | (Increase) decrease in trade receivables | 1 |
0000915389-25-000105 | 4 | 8 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | (Increase) decrease in inventories | 1 |
0000915389-25-000105 | 4 | 9 | CF | 0 | H | Increase Decrease In Accounts Payable Trade | us-gaap/2024 | Increase (decrease) in trade payables | 0 |
0000915389-25-000105 | 4 | 10 | CF | 0 | H | Pension And Other Postretirement Benefits Contributions In Excess Of Less Than Expenses | 0000915389-25-000105 | Pension and other postretirement contributions (in excess of) less than expenses | 1 |
0000915389-25-000105 | 4 | 11 | CF | 0 | H | Variable Cash Compensation In Excess Of Less Than Expenses | 0000915389-25-000105 | Variable compensation payments (in excess of) less than expenses | 1 |
0000915389-25-000105 | 4 | 12 | CF | 0 | H | Other Operating Activities Cash Flow Statement | us-gaap/2024 | Other items, net | 0 |
0000915389-25-000105 | 4 | 13 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
0000915389-25-000105 | 4 | 15 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Additions to properties and equipment | 1 |
0000915389-25-000105 | 4 | 16 | CF | 0 | H | Government Incentives Cash Received | 0000915389-25-000105 | Sales | 0 |
0000915389-25-000105 | 4 | 17 | CF | 0 | H | Payments For Proceeds From Other Investing Activities | us-gaap/2024 | Other items, net | 1 |
0000915389-25-000105 | 4 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
0000915389-25-000105 | 4 | 20 | CF | 0 | H | Proceeds From Repayments Of Short Term Debt | us-gaap/2024 | Net increase in commercial paper and other borrowings | 0 |
0000915389-25-000105 | 4 | 21 | CF | 0 | H | Proceeds From Issuance Of Long Term Debt | us-gaap/2024 | Proceeds from borrowings | 0 |
0000915389-25-000105 | 4 | 22 | CF | 0 | H | Repayments Of Long Term Debt | us-gaap/2024 | Repayment of borrowings | 1 |
0000915389-25-000105 | 4 | 23 | CF | 0 | H | Payments Of Dividends | us-gaap/2024 | Dividends paid to stockholders | 1 |
0000915389-25-000105 | 4 | 24 | CF | 0 | H | Proceeds From Payments For Other Financing Activities | us-gaap/2024 | Other items, net | 0 |
0000915389-25-000105 | 4 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash (used in) provided by financing activities | 0 |
0000915389-25-000105 | 4 | 26 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of exchange rate changes on cash and cash equivalents | 0 |
0000915389-25-000105 | 4 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash and cash equivalents | 0 |
0000915389-25-000105 | 4 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
0000915389-25-000105 | 4 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |